Navigation Links
New Research Conducted by University Cancer Centers Links BP Refinery Incident to Increase Occurrence of Cancer in Texas City
Date:2/15/2013

HOUSTON, Feb. 15, 2013 /PRNewswire-iReach/ -- The University Cancer Centers' pilot study demonstrated that benzene exposure has significant health risks, specifically, altering the blood cells and liver enzymes. This indicates the Texas City subjects exposed to benzene are at higher risk of developing hepatic or blood related cancer due to the inflammatory response it may produce in the bone marrow, which may be cytokine mediated or acute chemical hepatic toxicity.

The purpose of this study was to assess a cohort of subjects who underwent clinical evaluation, specifically, in relation to array of clinical findings characteristic of ambient exposure to benzene at the University Cancer Centers. In particular, the clinical findings of the subjects exposed to benzene evaluated and compared to the cohort of subjects who were not exposed to benzene.

In 2010, British petroleum (BP) refinery spewed tens of thousands of pounds of toxic chemicals into the skies of Texas city, Texas. Specifically, the release from the BP facility began April 6 and lasted 40 days due to a problem with a compressor on the refinery's ultracracker unit resulted in increased flaring as the unit continued to operate.

The scope of the problem was realized only after analyzing data from a monitor that measures emissions from a flare 300 feet above the ground that was supposed to incinerate the toxic chemicals. It is estimated that more than 500,000 pounds of chemicals, including benzene and carbon monoxide escaped from the refinery while it was replacing the equipment and contaminated the air surrounding the refinery.

A total of 200 subjects (benzene exposed, n=100 and non-exposed, n= 100) were included in this analysis. The mean age of subjects was 32.6 and 50.3 years in the exposed and non-exposed groups, respectively. White blood cells, platelets, hemoglobin and hematocrit were significantly higher in subjects in the benzene exposed group compared with those in the non-exposed groups. Alkaline phosphatase was significantly higher in subjects in the benzene exposed group compared with those in the non-exposed groups. Similarly, benzene exposed subjects experienced significantly higher levels of AST and ALT compared with non-exposed subjects.

This study was conducted at the University Cancer Centers in Houston, Texas, by Dr. Mark A. D'Andrea, MD, FACRO and Dr. G. Kesava Reddy , PhD, MHA, and will be presented at ARCO 2013 in San Antonio, Texas on Friday, February 15, 2013. Subjects exposed to benzene and non-exposed to benzene were included in the study. The benzene exposed subjects were residents of the Texas City, specifically living very close proximity to BP refinery plant. The non-exposed subjects were residents of Huston Suburbs who lived 30-40 miles away from the BP refinery plant. Blood and urine samples were collected, analyzed and compared between the benzene exposed and non-exposed subjects.

Media Contact: Alex Kutac Webranx, 7134894455, alex@webranx.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE University Cancer Centers
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
2. Research reveals first evidence of hunting by prehistoric Ohioans
3. Diabetes Research Institute develops oxygen-generating biomaterial
4. APS issues new policy requiring identification of sex or gender in reporting scientific research
5. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
6. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
7. U of Alberta researcher steps closer to understand autoimmune diseases
8. Research on flavanols and procyanidins provides new insights into how these phytonutrients may positively impact human health
9. A project to research biological and chemical aspects of microalgae to fuel approach
10. Scripps Research discoveries lead to newly approved drug for infant respiratory distress syndrome
11. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... , June 9, 2016 ... Police deploy Teleste,s video security solution to ensure the safety ... France during the major tournament Teleste, ... communications systems and services, announced today that its video security ... to back up public safety across the country. ...
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company , ... Watson Ads, an industry-first capability in which consumers will be ... able to ask questions via voice or text and receive ... Marketers have long sought an advertising ... that can be personal, relevant and valuable; and can scale ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016 /PRNewswire/ - Resverlogix Corp. ... the independent Data and Safety Monitoring Board (DSMB) ... high-risk cardiovascular disease (CVD) patients has completed a ... study should continue as planned without any modifications. ... that no safety or efficacy concerns were identified. ...
(Date:12/4/2016)... ... December 02, 2016 , ... A proposed five-year extension for ... funded research and development is welcome news for the photonics community, say leaders ... As part of the National Defense Authorization Act (NDAA) compromise agreement finalized today ...
(Date:12/2/2016)... , Dec. 2, 2016 More than $4.3 million ... Helix Medals dinner ( DHMD ). The gala was held at ... New York City and honored Alan Alda ... respectively, to health and medicine and the public understanding of ... in 2006, the event has raised $40 million for the ...
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ACEA Biosciences, ... its Phase I/II clinical trials for AC0010 at the World Conference on Lung Cancer ... providing an update on the phase I/II clinical trials for AC0010 in patients with ...
Breaking Biology Technology: